BioTales - Every Biotech Has a Story
Pull up a lab stool, pour yourself a (virtual) buffer, and join us as we binge the origin stories of today’s most intriguing biotech companies. Each episode zips from embryo-stage start-up sparks to headline-grabbing clinical wins—spotlighting the people, pivots and petri-dish plot twists along the way. We’ll unpack the wild science, admire the moon-shots, wince at the near-misses, and peek around the corner at what’s next for each pipeline.
Important disclaimer: every nugget of wisdom you’ll hear—research, script, the silky-smooth voices, and even this description—is generated by large language models and AI text-to-speech. Our human producer mostly wrangles prompts, sips coffee, and lets the algorithms do the heavy lifting. Translation: the content is informative—so double-check the numbers before you file that investor memo. Now, fire up your earbuds and let the biotech stories begin!
Views are my own and do not represent any affiliate. Content is based solely on publicly available information as of the recording date and is for educational purposes only. Nothing here is investment, legal, or medical advice. No confidential or non-public information was used.
- Update frequency
- every 3 days
- Average duration
- 21 minutes
- Episodes
- 10
- Years Active
- 2025
Skyhawk Therapeutics: Soaring Above the RNA Horizon
In this episode of BioTales, we uncover the remarkable story of Skyhawk Therapeutics – a biotech company with its wings firmly set on the frontiers of RNA biology. From a chance meeting on a humanita…
Inside Interius: How In Vivo CAR-T Therapy Went From Penn Lab to Kite’s $350M Deal
In this episode of BioTales, we dive into the creation of Interius BioTherapeutics, a company born from a physician’s frustration with traditional CAR-T therapy and propelled into the spotlight by an…
Holding Cancer Hostage: The Revolutionary Science Behind Halda Therapeutics and RIPTACs
This episode tells the extraordinary story of Halda Therapeutics, founded during the 2020 pandemic when renowned Yale professor Craig Crews gathered his team around an outdoor fireplace to brainstorm…
Peel Back the “Undruggable”: Kumquat’s Path to Cracking KRAS-Driven Cancers
What happens when a group of veteran chemists decide to take on one of oncology’s most notorious challenges? In this episode of BioTales, we explore the remarkable journey of Kumquat Biosciences—a b…
Wiring the Neuro-Immune Axis: How SetPoint Rewrote Autoimmune Care
This conversation explores the groundbreaking journey of SetPoint Medical, a company that aims to revolutionize the treatment of autoimmune diseases through neuroimmune modulation. Starting from a si…
Sitryx: The Promise of Immunometabolism in Rebalancing Immunity
This conversation delves into Sitryx Therapeutics, a pioneering company in the field of immunometabolism, aiming to revolutionize the treatment of autoimmune diseases by targeting metabolic pathways …
Reprogramming Immunity: The Story of Capstan Therapeutics
This conversation explores the groundbreaking advancements made by Capstan Therapeutics in the field of cell therapy, particularly focusing on their innovative approach to in vivo engineering and tar…
MoonLake Immunotherapeutics: The Biotech Ascent of a Nanobody Pioneer
This conversation delves into the journey of Moonlake Immunotherapeutics, a biotech company that has rapidly gained recognition in the field of immunology. The discussion covers the founders' vision,…